The use of romidepsin is uniformly associated with [[adverse drug reaction|adverse effects]].<ref name=label/> In clinical trials, the most common were [[nausea]] and [[vomiting]], [[fatigue (medical)|fatigue]], [[infection]], [[anorexia (symptom)|loss of appetite]], and blood disorders (including [[anemia]], [[thrombocytopenia]], and [[leukopenia]]). It has also been associated with infections, and with metabolic disturbances (such as abnormal [[electrolyte]] levels), skin reactions, [[dysgeusia|altered taste perception]], and changes in [[electrocardiography|cardiac electrical conduction]].<ref name=label/>

 

